Operator

Good morning, and welcome to KP Tissue's First Quarter 2026 Results Conference Call. Today's call is being recorded for replay. [Operator Instructions]

I will now turn the call over to Doris Grbic, Director of Investor Relations. You may begin your conference.

Doris Grbic

Thank you, operator. Good morning, everyone, and thank you for joining us to review Kruger Products First Quarter 2026 Financial results.

With me this morning is Dino Bianco, the CEO of KP Tissue and Kruger Products; and Michael Keays, the CFO of KP Tissue and Kruger Products.

Today's discussion will include certain forward-looking statements. Actual results could differ materially from these forward-looking statements due to known and unknown risks and uncertainties. A list of risk factors can be found in our public filings.

In addition, today's discussion will include certain non-GAAP financial measures. The reconciliation of these non-GAAP financial measures to the most comparable GAAP measure can be found in our MD&A.

The press release reporting our Q1 2026 results was published this morning and will be available on our website at kptissueinc.com. The financial statements and MD&A will also be posted on our website and on SEDAR+. The investor presentation to accompany today's discussion can be found in the Investor Relations section of our website.

I will now turn the call over to our CEO, Dino Bianco. Dino?

Dino Bianco
Chief Executive Officer

Thank you, Doris. Good morning, everyone, and thank you for joining us